Josiah Craver
Chief Accounting Officer
Faeth Therapeutics, Inc. (FTH)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Josiah Craver
Josiah Craver is recorded as Chief Accounting Officer and CFO at Faeth Therapeutics, Inc. (FTH). Faeth Therapeutics, Inc. reported in an 8-K filed June 15, 2026 that Josiah Craver was appointed Senior Vice President of Finance and principal accounting officer, effective June 13, 2026. Faeth Therapeutics, Inc. reported in an 8-K filed September 20, 2024 that Josiah Craver was appointed principal financial officer and principal accounting officer, effective September 17, 2024. The proxy statement of Faeth Therapeutics, Inc. reports total compensation of $409,710 for Josiah Craver in fiscal 2025, including a base salary of $372,650.
“Effective as of June 13, 2026, Josiah Craver was ratified as the Company’s Senior Vice President of Finance and appointed as principal accounting officer.”
“On September 17, 2024, the Board of Directors (the "Board") of Sensei Biotherapeutics, Inc. (the "Company") appointed Josiah Craver as the Company's principal financial officer and principal accounting officer, effective immediately (the "Effective Date").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-06-13–present
-
Current
2024-09-17–present
-
Faeth Therapeutics, Inc. (FTH)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Faeth Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Anand Parikh CEO, Chairman, COO, Board Member
- John Celebi CEO, Board Member
- William Ringo Chairman, Board Member
- Brian Stephenson CFO
- Christopher W. Gerry General Counsel, Board Member
- Bob Holmen Board Member
- Karen Vousden, Ph.D. Board Member
- Kristian Humer Board Member
- Phillip B. Donenberg Board Member
- Saira Ramasastry Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Faeth Therapeutics, Inc. (FTH) | SVP, Finance | $372,650 | $409,710 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.